Canada Pharmaceuticals

Curaleaf Holdings Inc (CURA)

Track

Over the past 90 days, Curaleaf Holdings Inc. saw 16 insider trading transactions resulting in a net negative value of approximately $760,620. Executives were the primary participants, with significant planned sales offsetting planned purchases. These activities follow the company's May 2026 earnings report, where the firm exceeded EPS expectations by over 200 percent.
Ticker: CURA Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Curaleaf Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 29 Jul 2026
Value US$3,863,618.10 | Price 320.30 | Shares 62,243 (-37.7%)
Planned sale 29 Jul 2026
Value US$490,951.76 | Price 483.13 | Shares 14,735 (-47.0%)
Planned buy 29 Jul 2026
Value US$100,000.00 | Price 1.48 | Shares 1,000 (+4.6%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-03 2026-07-29 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
62,243 -37.7%
320.30
US$3,863,618 		62,243 -37.7% 320.30 US$3,863,618
2026-08-03 2026-07-29 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
14,735 -47.0%
483.13
US$490,952 		14,735 -47.0% 483.13 US$490,952
2026-08-03 2026-07-29 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
66,691 -14.1%
366.54
US$3,156,804 		66,691 -14.1% 366.54 US$3,156,804
2026-07-17 2026-07-15 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
3,334 -0.7%
9.67
US$32,240 		3,334 -0.7% 9.67 US$32,240
2026-07-17 2026-07-15 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
10,000 -2.0%
9.67
US$96,661 		10,000 -2.0% 9.67 US$96,661
2026-07-17 2026-07-15 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
22,223 +4.7%
1.48
US$32,861 		22,223 +4.7% 1.48 US$32,861
2026-07-06 2026-07-01 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
3,334 -0.7%
9.97
US$33,240 		3,334 -0.7% 9.97 US$33,240
2026-07-06 2026-07-01 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
10,000 -2.1%
10.03
US$100,260 		10,000 -2.1% 10.03 US$100,260
2026-07-06 2026-07-01 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
22,223 +4.8%
1.48
US$32,861 		22,223 +4.8% 1.48 US$32,861
2026-06-26 2026-06-24 S Sale
Pinto, Rahul

Senior Officer of Issuer

Officer
82,452 -49.0%
9.23
US$760,620 		82,452 -49.0% 9.23 US$760,620
2026-06-26 2026-06-23 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
3,334 -0.7%
9.20
US$30,673 		3,334 -0.7% 9.20 US$30,673
2026-06-26 2026-06-23 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
15,621 -3.2%
9.22
US$144,015 		15,621 -3.2% 9.22 US$144,015
2026-06-26 2026-06-23 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
33,334 +7.4%
1.48
US$49,334 		33,334 +7.4% 1.48 US$49,334
2026-05-19 2026-05-14 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
10,000 -0.7%
3.99
US$39,896 		10,000 -0.7% 3.99 US$39,896
2026-05-19 2026-05-14 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
45,558 -3.3%
3.92
US$178,601 		45,558 -3.3% 3.92 US$178,601
2026-05-19 2026-05-14 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
100,000 +7.7%
0.49
US$49,290 		100,000 +7.7% 0.49 US$49,290
2026-05-08 2026-05-04 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
10,000 -0.8%
3.35
US$33,451 		10,000 -0.8% 3.35 US$33,451
2026-05-08 2026-05-04 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
46,304 -3.4%
3.42
US$158,346 		46,304 -3.4% 3.42 US$158,346
2026-05-08 2026-05-04 PP Planned purchase
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
100,000 +8.0%
0.49
US$49,290 		100,000 +8.0% 0.49 US$49,290
2026-04-21 2026-04-16 PlS Planned sale
2.0
Clateman, Peter Laurence

Senior Officer of Issuer

Officer
10,000 -0.8%
2.58
US$25,801 		10,000 -0.8% 2.58 US$25,801
Explore more

More insider trading research around Curaleaf Holdings Inc

More insider trades in Canada
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America